Press Releases - 2019-11-08

Date	Title	Company
08-Nov-2019	FDA approves first therapy to treat patients with rare blood disorder	U.S. Food and Drug Administration
08-Nov-2019	Akeso, Inc. Completes Series-D Private Financing for US$150 Million	Akeso, Inc.
08-Nov-2019	BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019	BioNTech SE
08-Nov-2019	Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in	Mallinckrodt plc
08-Nov-2019	Pooled Analyses of Bempedoic Acid Phase 3 LDL-C Lowering Clinical Trial Programme to be Presented at the American Heart Association 2019 Scientific Sessions	Daiichi Sankyo
08-Nov-2019	Bavarian Nordic Announces Submission of European Marketing Authorisation Applications for Investigational Ebola Vaccine Regimen	Bavarian Nordic A/S
08-Nov-2019	Bioeq announces Coherus as marketing and distribution partner for its biosimilar to Lucentis® (ranibizumab) in the U.S.	Bioeq
08-Nov-2019	Immutep presents positive interim data from phase II TACTI-002 trial at SITC	Immutep
08-Nov-2019	Mallinckrodt to Present at Jefferies London Healthcare Conference	Mallinckrodt plc
08-Nov-2019	UKI2S wins Best Sector Support Organisation at the OBN Awards	UKI2S
08-Nov-2019	OBN Awards 2019 – Winners Recognised at Industry Leading Event	OBN
08-Nov-2019	OBN Awards 2019 - Winners Recognised at Industry Leading Event	OBN
08-Nov-2019	RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in Revenues in the Third Quarter and in the First Nine Months	RHÖN-KLINIKUM AG
08-Nov-2019	Abcam and BrickBio Announce a Partnership to Incorporate Conjugation-Ready Sites into Recombinant Antibodies Across Abcam’s Portfolio	B3C newswire
08-Nov-2019	Camurus Announces That FDA Grants Braeburn's Citizen Petition, Eliminating the Risk of Further Blocking of Brixadi(TM) From the US market	Camurus AB
08-Nov-2019	Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes	Fresenius Kabi Deutschland GmbH